Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer.

Trial Profile

Pilot Study to Evaluate the Impact of Denosumab on Disseminated Tumor Cells (DTC) in Patients With Early Stage Breast Cancer.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 19 May 2016

At a glance

  • Drugs Denosumab (Primary)
  • Indications Early breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 May 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2018.
    • 11 May 2016 Status changed from recruiting to active, no longer recruiting.
    • 04 Mar 2015 Planned End Date changed from 1 Jan 2016 to 1 Dec 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top